Rifampicin loading of vascular grafts

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 6, 1996, Pages 1121-1129

  Malassiney, P ^a   Goeau Brissonniere O ^b   Coggia, M ^b   Pechere J C ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL EXPERIMENT; ARTERY PROSTHESIS; ARTICLE; BLOOD VESSEL GRAFT; DOG; DRUG ABSORPTION; DRUG RELEASE; GRAFT INFECTION; NONHUMAN;

ABSORPTION; ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL ASSAY; BLOOD VESSEL PROSTHESIS; DOGS; HUMANS; RIFAMPIN; TIME FACTORS; VASCULAR SURGICAL PROCEDURES;

EID: 0029781289     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.6.1121     Document Type: Article

References (15)

1. Ashton, T. R., Cunningham, J. D., Paton, D. & Maini, R. (1990). Antibiotic loading of vascular grafts. In Proceedings of the Sixteenth Annual Meeting of the Society for Biomaterials, Charleston, 1990. Abstract p. 235.
2. Bunt, T. J. (1983). Synthetic vascular graft infections. I. Graft infections. Surgery 93, 733-46.
3. Chervu, A., Moore, W. S., Chvapil, M. & Henderson, T. (1991a). Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with collagen release system. Journal of Vascular Surgery 13, 897-901.
4. Chervu, A., Moore, W. S., Gelabert, H. A., Colburn, M. D. & Chvapil, M. (1991b). Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system. Journal of Vascular Surgery 14, 521-5.
5. Gahtan, V., Esses, G., Bandyk, D. F., Nelson, R. T., Dupont, E. & Mills, J. L. (1994). Antistaphylococcal activity of rifampicin-bonded gelatin impregnated Dacron grafts. In Association of VA surgeons Meetings Abstracts. Vascular Forum 2, 94.
6. Goëau-Brissonnière, O., Leport, C., Bacourt, F., Lebrault, C., Comte, R. & Pechère, J. C. (1991). Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft. Annals of Vascular Surgery 5, 408-12.
7. Goëau-Brissonnière, O., Mercier, F., Nicolas, M. H., Bacourt, F., Coggia, M., Lebrault, C. et al. (1994). Treatment of vascular graft infection by in situ replacement with a rifampin bonded gelatin-sealed Dacron graft. Journal of Vascular Surgery 19, 739-41.
8. Goldstone, J. & Moore, W. S. (1974). Infection in vasular prostheses. Clinical manifestions and surgical management. American Journal of Surgery 128, 225-33.
9. Liekweg, W. J. & Greenfield, L. J. (1977). Vascular prosthetic infections: collected experience and results of treatment. Surgery 81, 335-42.
10. Lorentzen, J. E., Nielsen, O. M., Arendrup, H., Kimose, H. H., Bille, S., Andersen, J. et al. (1985). Vascular graft infection: an analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery 98, 81-6.
11. Malabarba, A., Ferrari, P., Depaoli, A., Gallo, G. G. & Cavalleri, B. (1986). Synthesis and conformation of some acetyl derivatives of rifampicin. Farmaco Scientifica 41, 131-50.
12. O'Hara, P. J., Hertzer, N. R., Beven, E. G. & Krajewski, L. P. (1986). Surgical management of infected abdominal aortic grafts: review of a 25 year experience. Journal of Vascular Surgery 3, 725-31.
13. Powell, T. W., Burnham, S. J. & Johnson, G. (1983). A passive system using rifampin to create an infection-resistant vascular prosthesis. Surgery 94, 765-9.
14. Richardson, R. L., Pate, J. W., Wolf, R. Y., Ledes, C. & Hopson, W. B. (1970). The outcome of antibiotic-soaked arterial grafts in guinea-pig wounds contaminated with E. coli or S. aureus. Journal of Thoracic and Cardiovascular Surgery 59, 635-7.
15. Szilagyi, D. E., Smith, R. F., Elliott, J. P. & Vrandecic, M. P. (1972). Infection in arterial reconstruction with synthetic grafts. Annals of Surgery 176, 321-33.